PuSH - Publikationsserver des Helmholtz Zentrums München

Zeitschriften-Browsing

22 Datensätze gefunden.
Zum Exportieren der Ergebnisse bitte einloggen.
▮◀ ◀◀ 1 ... 2 ... ▶▶ ▶▮
Alle Publikationen dieser Seite in den Korb legen
1.
Trischitta, V.* et al.: Correction: GALNT2 expression is associated with glucose control and serum metabolites in patients with type 2 diabetes. Acta Diabetol. 61, 1015-1015 (2024)
2.
Trischitta, V.* et al.: GALNT2 expression is associated with glucose control and serum metabolites in patients with type 2 diabetes. Acta Diabetol. 61, 1007-1013 (2024)
3.
Casas, R.* et al.: Intra-lymphatic administration of GAD-alum in type 1 diabetes: Long-term follow-up and effect of a late booster dose (the DIAGNODE Extension trial). Acta Diabetol. 59, 687-696 (2022)
4.
Schmitz, T.* et al.: Prognostic value of stress hyperglycemia ratio on short- and long-term mortality after acute myocardial infarction. Acta Diabetol. 59, 1019-1029 (2022)
5.
Kabisch, S.* et al.: Dose-dependent effects of insoluble fibre on glucose metabolism: A stratified post hoc analysis of the Optimal Fibre Trial (OptiFiT). Acta Diabetol., DOI: 10.1007/s00592-021-01772-0 (2021)
6.
Ferrari, U.* et al.: Longitudinal association of type 2 diabetes and insulin therapy with muscle parameters in the KORA-Age study. Acta Diabetol. 57, 1057-1063 (2020)
7.
Greiner, G. et al.: Toward targeted prevention: Risk factors for prediabetes defined by impaired fasting glucose, impaired glucose tolerance and increased HbA1c in the population-based KORA study from Germany. Acta Diabetol. 57, 1481-1491 (2020)
8.
Klöting, N. ; Kern, M.* ; Moruzzi, M.* ; Stumvoll, M. & Blüher, M.: Tamoxifen treatment causes early hepatic insulin resistance. Acta Diabetol. 57, 495-498 (2020)
9.
Mühlenbruch, K.* et al.: Selecting the optimal risk threshold of diabetes risk scores to identify high-risk individuals for diabetes prevention: A cost-effectiveness analysis. Acta Diabetol. 57, 447-454 (2020)
10.
Hippich, M. et al.: Searching peripheral blood mononuclear cells of children with viral respiratory tract infections preceding islet autoimmunity for viruses by high-throughput sequencing. Acta Diabetol. 55, 881-884 (2018)
11.
Liberati, D.* et al.: A novel LIPS assay for insulin autoantibodies. Acta Diabetol. 55, 263–270 (2018)
12.
Mendler, M.* et al.: Urine levels of 5-aminoimidazole-4-carboxamide riboside (AICAR) in patients with type 2 diabetes. Acta Diabetol. 55, 585-592 (2018)
13.
Köhler, M. et al.: Joint modeling of longitudinal autoantibody patterns and progression to type 1 diabetes: Results from the TEDDY study. Acta Diabetol. 54, 1009–1017 (2017)
14.
Wagner, R. et al.: Erratum to: A novel insulin sensitivity index particularly suitable to measure insulin sensitivity during gestation. Acta Diabetol. 54, 713-714 (2017)
15.
Köhler, M. ; Ziegler, A.-G. & Beyerlein, A.: Development of a simple tool to predict the risk of postpartum diabetes in women with gestational diabetes mellitus. Acta Diabetol. 53, 433-437 (2016)
16.
Wagner, R. et al.: A novel insulin sensitivity index particularly suitable to measure insulin sensitivity during gestation. Acta Diabetol. 53, 1037-1044 (2016)
17.
Chmiel, R. et al.: Early infant feeding and risk of developing islet autoimmunity and type 1 diabetes. Acta Diabetol. 52, 621-624 (2015)
18.
Then, C. et al.: Plasma copeptin is associated with type 2 diabetes in men but not in women in the population-based KORA F4 study. Acta Diabetol. 52, 103-112 (2015)
19.
Bonifacio, E.* ; Krumsiek, J. ; Winkler, C. ; Theis, F.J. & Ziegler, A.-G.: A strategy to find gene combinations that identify children who progress rapidly to type 1 diabetes after islet autoantibody seroconversion. Acta Diabetol. 51, 403-411 (2014)
20.
Krause, S. et al.: Soluble interleukin-2 receptor alpha in preclinical type 1 diabetes. Acta Diabetol. 51, 517-518 (2014)
▮◀ ◀◀ 1 ... 2 ... ▶▶ ▶▮